Filing Flows

Filing Flows › Healthstream (HSTM) › Q3 2025

Healthstream (HSTM) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 6, 2025

Healthstream (HSTM) reported revenue of $76.5M for the third quarter 2025 (Q3 2025), +5% from a year earlier and +3% from the quarter before. Operating margin was 9.9%, net earnings $6.1M (8.0% of revenue).

Revenue$76.5M
Year over year+5%
Quarter over quarter+3%
Operating margin9.9%
Net earnings$6.1M

Healthstream, Q3 2025: revenue $76.5M (+5% year over year), operating margin 9.9%, net earnings $6.1M, operating cash flow $18.0M. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$76.5M+3%+5%
Operating profit$7.6M+29%+16%
Net earnings$6.1M+13%+6%
Operating cash flow$18.0M+259%-6%
Free cash flow$17.9M+562%-5%

What changed

Revenue was $76.5M in Q3 2025, up 5% year over year and up 3% from the previous quarter. Subscription Services was the largest line at 97% of revenue. Subscription Services added $4.0M year over year (up 6%), 117% of the total change. Professional Services declined 19%.

Operating profit was $7.6M, a 9.9% margin (up 1.0 points year over year). Of the extra revenue versus a year earlier, 32% reached operating profit, above the 9% margin then. Total costs grew 3% against revenue growth of 5%. Net earnings were $6.1M, up 6% year over year. The effective tax rate was 26.2%.

Operating cash flow was $18.0M (down 6% year over year), 296% of net earnings. Non-cash charges added back $10.8M of depreciation and amortization and $794K of share-based compensation. Capital expenditures of $109K left free cash flow of $17.9M.

Questions

What was Healthstream's revenue in the third quarter 2025?

Healthstream (HSTM) reported revenue of $76.5M for the third quarter 2025 (Q3 2025), +5% from a year earlier and +3% from the quarter before.

Was Healthstream profitable in the third quarter 2025?

Operating profit was $7.6M (9.9% of revenue) and net earnings $6.1M.

Open the interactive Sankey →

Source: Healthstream 10-Q on SEC EDGAR.